Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02560103 · ClinicalTrials.gov registry record
An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
A clinical trial of Jet Lag Disorder, sponsored by Vanda Pharmaceuticals.
- Completed
- Registry status
- 119
- Enrollment target
- 2
- Study locations
NCT02560103: Completed study of Jet Lag Disorder, sponsored by Vanda Pharmaceuticals.
NCT02560103 is a study of Jet Lag Disorder that has completed, run by Vanda Pharmaceuticals. The registered enrollment target is 119 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02560103, a study of Jet Lag Disorder, has completed, sponsored by Vanda Pharmaceuticals.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 2
- Study locations
Study Summary
Observational study to investigate circadian rhythm patterns
Conditions Studied
Interventions
- OTHER Transmeridian travel across multiple time zones
Study Locations (2)
California
- Santa Monica Clinical Trials - Santa Monica
Maryland
- The Center for Sleep & Wake Disorders - Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-10 |
What the finished NCT02560103 record still lists
NCT02560103 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Jet Lag Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transmeridian travel across multiple time zones is the first listed.
NCT02560103 reports a single indexed study location in California, Maryland.
Frequently Asked Questions
What is clinical trial NCT02560103 about?
NCT02560103 is a clinical study titled "An Observational Study to Investigate the Effects of Rapid Transmeridian Travel". Observational study to investigate circadian rhythm patterns
What is the current status of trial NCT02560103?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2015-09. Estimated completion is 2017-10.
What conditions does trial NCT02560103 study?
This clinical trial studies the following conditions: Jet Lag Disorder.
What interventions are being tested in trial NCT02560103?
The interventions under investigation include: Transmeridian travel across multiple time zones (OTHER).
Who is sponsoring clinical trial NCT02560103?
This trial is sponsored by Vanda Pharmaceuticals, which has 68 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02560103 being conducted?
This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Jet Lag Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia